Back to results
US 2003/0229117 A1Published application
Cystic fibrosis medicaments
AssigneeUniversity of Wales College of Medicine
InventorsRobert Leslie Dormer, Margaret Ann McPherson
Life of this patent
Estimating the term…
Abstract
The use of a type V cyclic nucleotide phosphodiesterase inhibitor for the preparation of a medicament for the treatment of cystic fibrosis.
Claims9
A method of treating cystic fibrosis in a patient, comprising:
- administering to said patient an effective amount of a type V cyclic nucleotide phosphodiesterase inhibitor.
A method of treating cystic fibrosis in a patient comprising:
- administering to said patient an effective amount of a type V cyclic nucleotide phosphodisterase inhibitor,
- wherein said inhibitor is a compound of formula (III):
- 21
- wherein A is a five- or six-membered ring containing one or more N atoms, X is a substituent of formula (II):
- 22
- wherein R1 represents C1-4 alkyl, and
- X is positioned at either or both of the 2-position and/or the 8-position in (III).
4 more elements
Dependencies are inferred from the claim text.